Galectin Therapeutics (GALT) P/E (2011 - 2026)
Galectin Therapeutics (GALT) P/E from Mar 31, 2011 to Jun 12, 2026. The TTM Galectin Therapeutics (GALT) P/E is -6.59. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Galectin Therapeutics (GALT)
| Year | P/E | Change |
|---|---|---|
| 2026 | -6.59 | -23.87% |
| 2025 | -8.65 | +405.15% |
| 2024 | -1.71 | -28.40% |
| 2023 | -2.39 | +26.04% |
| 2022 | -1.90 | -52.44% |
| 2021 | -3.99 | -26.67% |
| 2020 | -5.44 | -53.49% |
| 2019 | -11.70 | +18.92% |
| 2018 | -9.84 | +57.52% |
| 2017 | -6.25 | +371.34% |
| 2016 | -1.33 | -34.80% |
| 2015 | -2.03 | -58.08% |
| 2014 | -4.85 | -57.60% |
| 2013 | -11.44 | +239.98% |
| 2012 | -3.36 | -62.83% |
| 2011 | -9.05 | N/A |
Comparison Galectin Therapeutics (GALT) P/E with competitors
Galectin Therapeutics (GALT) P/E is -6.59.